MedTrace Logo

Hydrocortisone Vs Prednisolone in AI (HYPER-AID)

NCT03608943 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-11-29

No results posted yet for this study

Summary

This study is designed to collect data on individuals with adrenal insufficiency who are changing treatments from hydrocortisone to prednisolone, or vice versa. It will compare anthropometric, biochemical and subjective health outcomes between both treatments.

Conditions

Interventions

OTHER

There is no specific intervention other than an individual changing their treatment as part of their usual care

There is no specific intervention other than an individual changing their treatment as part of their usual care

Sponsors & Collaborators

  • Imperial College London

    lead OTHER

Principal Investigators

  • Karim Meeran, MBBS BSc MD · Imperial College London

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-24
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03608943 on ClinicalTrials.gov